Evercore ISI initiates Trex Bio at Outperform with a $28 price target
Evercore ISI started covering Trex Bio shares with an Outperform rating and a $28 target. TradingView says the target implies a 105.3% gain from the November 2 close.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Evercore ISI Group initiated coverage of Trex Bio with an Outperform rating and a $28 price target, TradingView reports. The target implies potential upside of 105.3% from the November 2 close of $13.64. Dow Jones Newswires separately reported the same $28 target from Evercore ISI.
Based on Benzinga data cited by TradingView, other recent notes include JP Morgan at Overweight with a $20 target, Stifel at Buy with $39 and Wedbush at Outperform with $30. Cantor Fitzgerald started coverage at Overweight without a target. Across the four latest notes over the past 30 days, targets range from $20 to $39.
why it matters
Initiation reports are routine for analysts and usually move a small-cap stock less than changes in its fundamentals do. The wide spread between targets here shows that banks covering the shares hold clearly different views.
tags
instruments
sources
- Evercore ISI Group initiates coverage of Trex Bio at Outperform, sets price target at $28 — TradingView, 3 November 2026 at 15:52 UTC
- TRex Bio Price Target Announced at $28.00/Share by Evercore ISI Group — Dow Jones Newswires, 3 November 2026 at 16:03 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗